NSE - Delayed Quote INR

KRONOX LAB SCIENCES LTD (KRONOX.NS)

143.40
+2.37
+(1.68%)
At close: May 16 at 3:29:50 PM GMT+5:30
Loading Chart for KRONOX.NS
  • Previous Close 141.03
  • Open 141.00
  • Bid --
  • Ask --
  • Day's Range 141.00 - 143.90
  • 52 Week Range 132.05 - 228.88
  • Volume 89,710
  • Avg. Volume 102,146
  • Market Cap (intraday) 5.321B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 29.57
  • EPS (TTM) 4.85
  • Earnings Date --
  • Forward Dividend & Yield 0.50 (0.35%)
  • Ex-Dividend Date Aug 23, 2024
  • 1y Target Est --

Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents, such as ACS reagents, and LR, AR and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, including tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous. The company was incorporated in 2008 and is based in Vadodara, India.

www.kronoxlabsciences.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: KRONOX.NS

View More

Performance Overview: KRONOX.NS

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

KRONOX.NS
28.21%
S&P BSE SENSEX (^BSESN)
5.36%

1-Year Return

KRONOX.NS
13.06%
S&P BSE SENSEX (^BSESN)
11.77%

3-Year Return

KRONOX.NS
13.06%
S&P BSE SENSEX (^BSESN)
55.42%

5-Year Return

KRONOX.NS
13.06%
S&P BSE SENSEX (^BSESN)
164.75%

Compare To: KRONOX.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KRONOX.NS

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    5.32B

  • Enterprise Value

    5.18B

  • Trailing P/E

    29.57

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.97

  • Price/Book (mrq)

    6.90

  • Enterprise Value/Revenue

    5.81

  • Enterprise Value/EBITDA

    20.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.01%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    962.39M

  • Net Income Avi to Common (ttm)

    250.34M

  • Diluted EPS (ttm)

    4.85

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    193.92M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: KRONOX.NS

View More

People Also Watch